Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2014
05/27/2014US8735360 Treatments for gastrointestinal disorders
05/27/2014US8735359 Combinations of modalities for the treatment of diabetes
05/27/2014US8735358 Methods for treating cancer by regulation of tumor necrosis factor-alpha
05/27/2014US8735357 Method of inducing antigen-specific T cells
05/27/2014US8735356 Anticonvulsant combination therapy
05/27/2014US8735355 Methods of use of fragments of secreted frizzled related protein, sFRP
05/27/2014US8735354 Endothelium mimicking nanomatrix
05/27/2014US8735353 Polypeptides and uses thereof
05/27/2014US8735352 Adsorbent for blood coagulation factor or cell adhesion factor and method for purifying the factor
05/27/2014US8735351 Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof
05/27/2014US8735350 Reversible pegylated drugs
05/27/2014US8735349 Method for improving glucose tolerance in a diabetes type 2 patient of younger than 50 years and having postprandial plasma glucose concentration of at least 14 mmol/L
05/27/2014US8735348 Casein derived peptides and uses thereof
05/27/2014US8735347 Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling
05/27/2014US8735346 HCV-derived polypeptides and uses thereof
05/27/2014US8735345 Therapeutic composition
05/27/2014US8735344 Sustained release of APO A-I mimetic peptides and methods of treatment
05/27/2014US8735343 Product and process for liquefaction of mucus or sputum
05/27/2014US8735342 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
05/27/2014US8735341 Non-viral delivery of compounds to mitochondria
05/27/2014US8735340 Conjugates that contain the homeodomain of antennapedia
05/27/2014US8735171 Promyelocytic leukemia protein as a redox sensor
05/27/2014US8735145 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
05/27/2014US8735127 Methods of and compositions for inhibiting the proliferation of mammalian cells
05/27/2014US8735126 Disease control with tick phospholipase A2
05/27/2014US8735124 Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
05/27/2014US8735122 Method for the purification of heat shock proteins
05/27/2014US8735097 Human antibiotic proteins
05/27/2014US8735092 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof
05/27/2014US8735087 Use of alkaline phosphatase for preventing or reducing liver disease
05/27/2014US8735066 Tumor suppressor designated TS10Q23.3
05/27/2014US8734854 Process for removing growth factors from platelets
05/27/2014US8734849 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
05/27/2014US8734830 Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
05/27/2014US8734827 Bioengineered intervertebral discs and methods for their preparation
05/27/2014US8734812 Neisserial antigenic peptides
05/27/2014US8734810 Botulinum toxin treatments of neurological and neuropsychiatric disorders
05/27/2014US8734799 Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer
05/27/2014US8734789 Targets for regulation of angiogenesis
05/27/2014US8734787 Drug delivery system
05/27/2014US8734776 Mutants of IL-29
05/27/2014US8734775 Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments
05/27/2014US8734774 Protease activated cytokines
05/27/2014US8734760 Antagonists of ligands and uses thereof
05/27/2014US8734527 Encapsulated kidney tissue
05/27/2014CA2727634C Calcium fluoride phosphate complexes
05/27/2014CA2726861C Devices, formulations, and methods for delivery of multiple beneficial agents
05/27/2014CA2619735C Treatment of inflammatory bowel disease
05/27/2014CA2609188C Apo-2 ligand/trail formulations
05/27/2014CA2597255C Natural ligand of g protein coupled receptor rcc356 and uses thereof
05/27/2014CA2568750C Compositions and methods for treatment of neovascular diseases
05/27/2014CA2561833C Oligopeptides for reducing elevated blood urea concentration
05/27/2014CA2547618C Botulinum toxin treatment
05/27/2014CA2525243C Use of melanotransferrin (p97) for regulating plasminogen activation and cell migration
05/27/2014CA2497552C Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
05/27/2014CA2470511C Liquid composition of factor vii polypeptides
05/27/2014CA2460685C Cyclosporine analogue mixtures and their use as immunomodulating agents
05/27/2014CA2375992C Method for controlled production of ultrafine microparticles and nanoparticles
05/27/2014CA2371814C Trpm-2 antisense therapy
05/27/2014CA2343335C Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
05/27/2014CA2310228C Attaching substances to micro-organisms
05/27/2014CA2298855C Interleukin-18 binding proteins, their preparation and use
05/27/2014CA2283143C Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
05/26/2014CA2834538A1 Use of an enzyme complex for feeding farm animals
05/22/2014WO2014078787A1 Stem cell mobilization and tissue repair and regeneration
05/22/2014WO2014078656A1 Gonorrheal mtre peptides and vaccines
05/22/2014WO2014078655A1 Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor
05/22/2014WO2014078622A1 Method and system for diagnosing and treating preeclampsia
05/22/2014WO2014078581A1 Stable thermolysin hydrogel
05/22/2014WO2014078579A1 Differentiation of human fibroblast cells
05/22/2014WO2014078533A1 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same
05/22/2014WO2014078522A1 Materials and methods useful for treating glioblastoma
05/22/2014WO2014078459A1 Compositions and methods for increasing energy metabolism
05/22/2014WO2014078383A1 Inhibition of drug resistant cancer cells
05/22/2014WO2014078353A1 Compositions and methods for the treatment of ectodermal dysplasia
05/22/2014WO2014078272A1 Methods and materials for assessing immune system profiles
05/22/2014WO2014078081A1 Cross-linked collagen comprising metallic anticancer agents
05/22/2014WO2014078080A1 Cross-linked collagen with a bound antimicrobial agent
05/22/2014WO2014077825A1 Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)
05/22/2014WO2014077802A1 Purification method of a glp-1 analogue
05/22/2014WO2014077784A1 Method of treating cancer
05/22/2014WO2014077629A1 Biodegradable microbeads with improved anticancer drug adsorptivity, containing albumin and dextran sulfate, and preparation method therefor
05/22/2014WO2014077568A1 Composition for external use skin preparation, containing thioredoxin
05/22/2014WO2014077409A1 Agent for mitigating side effect of sunitinib
05/22/2014WO2014077358A1 Radiation exposure treatment agent and radiation exposure treatment method
05/22/2014WO2014077244A1 Transdermal absorption sheet, and manufacturing method for same
05/22/2014WO2014077242A1 Method for manufacturing transdermal-absorption sheet
05/22/2014WO2014077088A1 Method for producing fired product of freshwater clam shell, and composition for ameliorating hepatic dysfunction which contains said fired product as active ingredient
05/22/2014WO2014076702A1 Combination treatment for amyotrophic lateral sclerosis (als)
05/22/2014WO2014076655A1 Polypeptides for blood brain barrier transport
05/22/2014WO2014076567A1 Compositions and methods for treating inflammatory diseases of infectious and non-infectious origin
05/22/2014WO2014076423A1 Quick-acting insulin formulation including a substituted anionic compound
05/22/2014WO2014076321A1 Novel specific-binding polypeptides and uses thereof
05/22/2014WO2014076270A1 Soluble collagen vi for use in the treatment of hyperglycemia linked diseases and glucose transport disorders. pharmaceutical composition, method and use of a cell extracellular liquid medium for increasing glucose uptake
05/22/2014WO2014076235A1 Modulators of intracellular chloride concentration for treating fragile x syndrome
05/22/2014WO2014076231A1 Single dose recombinant bovine fsh after follicular synchronisation
05/22/2014WO2014076179A1 New polypeptide
05/22/2014WO2014076177A1 New polypeptide
05/22/2014WO2014075592A1 Mesenchymal stem cell injection and preparation method thereof and use in preparing drugs for treating dilated cardiomyopathy in children
05/22/2014WO2014075589A1 Mesenchymal stem cell injection, preparation method thereof, and application thereof in preparing diabetes drug
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 3163